Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii

Schizophrenia Research

Volumn 62, Issue 3, 2003, Pages 237-244

  Jones Brando, Lorraine ^a   Torrey, E Fuller ^b   Yolken, Robert ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanley Foundation   (United States)

Author keywords

Antiparasitic; Antipsychotics; Bipolar disorder; Mood stabilizers; Parasite; Schizophrenia

Indexed keywords

ANTIBIOTIC AGENT; BETA GALACTOSIDASE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LITHIUM CARBONATE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; TRIMETHOPRIM; VALPROIC ACID;

ARTICLE; BIPOLAR DISORDER; BLOOD; CEREBROSPINAL FLUID; COLORIMETRY; CONTROLLED STUDY; CYTOPLASM; DNA MODIFICATION; DRUG ACTIVITY; DRUG POTENTIATION; DRUG RESEARCH; DRUG SCREENING; DRUG USE; FIBROBLAST; GROWTH; HUMAN; HUMAN CELL; IN VITRO STUDY; MOOD; PARASITE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SPECTROPHOTOMETRY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0037787955     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(02)00357-2     Document Type: Article

References (56)

1. Amsterdam J.D., Potter L., Giuntoli R. Prevention of recurrent genital herpes simplex virus infections with lithium carbonate [abstract]. Second World Conference on Viruses, Immunity and Mental Disorders, Mont Gabriel, Quebec, Oct. 3-7, 1988.
2. Amsterdam J.D., Maislin G., Rybakowski J. A possible antiviral action of lithium carbonate in herpes simplex virus infections. Biol. Psychiatry. 27:1990;447-453.
3. Amsterdam J.D., García-España F., Rybakowski J. Rates of flu-like infection in patients with affective illness. J. Affect. Disord. 47:1998;177-182.
4. Benson T.J., McKie J.H., Garforth J., Borges A., Fairlamb A.H., Douglas K.T. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. Biochem. J. 286:1992;9-11.
5. Bohn W., Rutter G., Hohenberg H., Mannweiler K. Inhibition of measles virus budding by phenothiazines. Virology. 130:1983;44-55.
6. Calabrese J.R., Rapport D.J., Shelton M.D., Kimmel S.E. Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology. 38:1998;185-191.
7. Candurra N.A., Maskin L., Damonte E.B. Inhibition of arenavirus multiplication in vitro by phenothiazines. Antivir. Res. 31:1996;149-158.
8. 2+] and stimulate microneme discharge in Toxoplasma gondii. Biochem. J. 342:1999;379-386.
9. Cernescu C., Popescu L., Constantinescu S., Cernescu S. Antiviral effect of lithium chloride. Virologie. 39:1988;93-101.
10. Chang T.-W. Suppression of herpetic recurrence by chlorpromazine [letter]. N. Engl. J. Med. 293:1975;153-154.
11. Chapman A., Keane P.E., Meldrum B.S., Simiand J., Vernieres J.C. Mechanisms of anticonvulsant action of valproate. Prog. Neurobiol. 19:1982;315-359.
12. Corbascio A.N., Bufalini L.V. Possible neuroleptic-induced resistance to the human immunodeficiency virus [letter]. West. J. Med. 150:1989;92-93.
13. Flegr J., Hrdý I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol. 41:1994;122-126.
14. Forrest I.S., Quesada F., Deitchman G.L. Unicellular organisms as model systems for the mode of action of phenothiazine and related drugs. Proc. West. Pharmacol. Soc. 6:1963;42-44.
15. Garcia L.S., Sulzer A.J., Healy G.R., Grady K.K., Bruckner D.A. Blood and tissue protozoa. Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H. Manual of Clinical Microbiology. 6th ed. 1995;1171-1195 ASM Press, Washington, DC.
16. Gu H., Yolken R.H., Phillips M., Yang F., Bilder R.M., Gilmore J.H., Lieberman J.A. Evidence of Toxoplasma gondii infection in recent-onset schizophrenia [abstract]. Schizophr. Res. 49:2001;53.
17. Gutierrez-Correa J., Fairlamb A.H., Stoppani A.O. Trypanosoma cruzi trypanothione reductase is inactivated by peroxidase-generated phenothiazine cationic radicals. Free Radic. Res. 34:2001;363-378.
18. Guttman P., Ehrlich P. Uber die wirkung des Methylenblau bei Malaria. Berl. Klin. Wochenschr. 39:1891;953-956.
19. Henriksen T.-H., Lende S. Treatment of diffuse cutaneous leishmaniasis with chlorpromazine ointment [letter]. Lancet. i:1983;26.
20. Hewlett I., Lee S., Molnar J., Foldeak S., Pine P.S., Weaver J.L., Aszalos A. Inhibition of HIV infection of H9 cells by chlorpromazine derivatives. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 15:1997;16-20.
21. Israelski D.M., Remington J.S. Toxoplasmic encephalitis in patients with AIDS. Infect. Dis. Clin. North Am. 2:1988;429-445.
22. 2+ channel current in PC12 cells. Eur. J. Pharmacol. 314:1996;143-150.
23. Johannessen C.U. Mechanisms of action of valproate: a commentatory. Neurochem. Int. 37:2000;103-110.
24. Jones-Brando L.V., Buthod J.L., Holland L.E., Yolken R.H., Torrey E.F. Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1. Schizophr. Res. 25:1997;63-70.
25. 2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am. J. Psychiatry. 157:2000;514-520.
26. Kramer W. Frontiers of neurological diagnosis in acquired toxoplasmosis. Psychiatr. Neurol. Neurochir. 69:1966;43-64.
27. Kristiansen J.E., Hansen J.B. Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia. Int. J. Antimicrob. Agents. 14:2000;209-213.
28. Kristiansen J.E., Jepsen S. The susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereo-isomeric compounds cis(Z)- and trans(E)-clopenthixol. Acta Pathol. Microbiol. Immunol. Scand. B. 93:1985;249-251.
29. Kristiansen J.E., Andersen L.P., Vestergaard B.F., Hvidberg E.F. Effect of selected neuroleptic agents and stereo-isomeric analogues on virus and eukaryotic cells. Pharmacol. Toxicol. 69:1991;399-403.
30. Krizanová O., Ciampor F., Veber P. Influence of chlorpromazine on the replication of influenza virus in chicken embryo cells. Acta Virol. 26:1982;209-216.
31. Ladee G.A. Diagnostic problems in psychiatry with regard to acquired toxoplasmosis. Psychiatr. Neurol. Neurochir. 69:1966;65-82.
32. Libíkowa H., Stanček D., Wiedermann V., Hašto J., Breier Š. Psychopharmaca and electroconvulsive therapy in relation to viral antibodies and interferon: experimental and clinical study. Arch. Immunol. Ther. Exp. 25:1977;641-649.
33. Lieb J. Remission of recurrent herpes infection during therapy with lithium. N. Engl. J. Med. 301:1979;942.
34. Loddo B., Zanda G.E. Influenze derivati della fenotiazina sulla moltiplicazone "In vitro" di cellule vegitali di microorganismi, di virus. Arch. Int. Pharmacodyn. 133(1-2):1961;1-9.
35. McFadden D.C., Seeber F., Boothroyd J.C. Use of Toxoplasma gondii expressing β-galactosidase for colorimetric assessment of drug activity in vitro. Antimicrob. Agents Chemother. 41:1997;1849-1853.
36. Minto A., Roberts F.J. The psychiatric complications of toxoplasmosis. Lancet. i:1959;1180-1182.
37. Nemerow G.R., Cooper N.R. Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists. Proc. Natl. Acad. Sci. U. S. A. 81:1984;4955-4959.
38. Ondarza R.N., Hernández E., Itrube A., Hrtado G. Inhibitory and lytic effects of phenothiazine derivatives and related tricyclic neuroleptic compounds on Entamoeba histolytica HK9 and HMI trophozoites. Biotechnol. Appl. Biochem. 32:2000;61-67.
39. Patou G., Crow T.J., Taylor G.R. The effects of psychotropic drugs on synthesis of DNA and the infectivity of herpes simplex virus. Biol. Psychiatry. 21:1986;1221-1225.
40. Pearson R.D., Manian A.A., Hall D., Haracus J.L., Hewlett E.L. Antileishmanial activity of chlorpromazine. Antimicrob. Agents Chemother. 25:1984;571-574.
41. Pezzella N., Bouchot A., Bonhomme A., Pingret L., Klein C., Burlet H.et al. Involvement of calcium and calmodulin in Toxoplasma gondii tachyzoite invasion. Eur. J. Cell Biol. 74:1997;92-101.
42. Prokopenko R.A., Mogilevich S.E., Luik A.I., Naydyenova I.Y., Batrak G.N., Hawryluk B.R.et al. Effects of haloperidol and chlorpromazine on smooth muscle contractility, platelet aggregation and neuronal calcium current. Gen. Physiol. Biophys. 14:1995;349-357.
43. Qiuying L., Xiaonian L., Li L.et al. The control study of schizophrenia and affective disorders and toxoplasma infections. Acta Acad. Med. Hubei. 20:1999;223-225.
44. Saitow F., Nakaoka Y. The photodynamic action of methylene blue on the ion channels of Paramecium causes cell damage. Photochem. Photobiol. 65:1997;902-907.
45. Seebeck T., Gehr P. Trypanocidal action of neuroleptic phenothiazines in Trypanosoma brucei. Mol. Biochem. Parasitol. 9:1983;197-208.
46. Skinner G.R.B. Lithium ointment for genital herpes. Lancet. ii:1983;288.
47. Skinner G.R.B., Hartley C., Buchan A., Harper L., Gallimore P. The effect of lithium chloride on the replication of herpes simplex virus. Med. Microbiol. Immunol. 168:1980;139-148.
48. Torrey E.F. Stalking the schizovirus. Schizophr. Bull. 14:1988;223-229.
49. Trousdale M.D., Gordon Y.J., Peters A.C.B., Gropen T.I., Nelson E., Nesburn A.B. Evaluation of lithium as an inhibitory agent of herpes simplex virus in cell cultures and during reactivation of latent infection in rabbits. Antimicrob. Agents Chemother. 25:1984;522-523.
50. Webster J.P. Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect. 3:2001;1037-1045.
51. Wu S.N., Jan C.R., Li H.F., Chiang H.T. Characterization of the inhibition by risperidone of the inwardly rectifying K(+) current in pituitary GH(3) cells. Neuropsychopharmacology. 23:2000;676-689.
52. Wunderlich V., Sydow G. Lytic action of neurotropic drugs on retroviruses in vitro. Eur. J. Cancer. 16:1980;1127-1132.
53. Wunderlich V., Zotter S.T. Abrogation of infectivity of mouse mammary tumor virus by reserpine. Exp. Pathol. 21:1982;59-61.
54. Wunderlich V., Fey F., Sydow G. Antiviral effect of haloperidol on Rauscher murine leukemia virus. Arch. Geschwulstforsch. 50:1980;758-762.
55. Yolken R.H., Bachmann S., Rouslanova I., Lillehoj E., Ford G., Torrey E.F., Schroeder J. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin. Infect. Dis. 32:2001;842-844.
56. Ziaie Z., Kefalides N.A. Lithium chloride restores host protein synthesis in herpes simplex virus-infected endothelial cells. Biochem. Biophys. Res. Commun. 160:1989;1073-1078.